Last reviewed · How we verify
NCT05412485
Gait Improvement After Increased Frequency of Robot-assisted Gait Training in Cerebral Palsy Children
NA trial testing Robotic assisted gait training in Cerebral Palsy Spastic Diplegia in 20 participants. Status unknown.
30 July 2022
Quick facts
| Lead sponsor | University of Sharjah |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 7 June 2022 |
| Primary completion | 30 July 2022 |
| Estimated completion | 30 July 2022 |
| Sites | 1 location across United Arab Emirates |
Drugs / interventions tested
- Robotic assisted gait training
Conditions studied
- Cerebral Palsy Spastic Diplegia — all drugs for Cerebral Palsy Spastic Diplegia →
Sponsor
University of Sharjah
Who can join
Adults 6 to 14, any sex, with Cerebral Palsy Spastic Diplegia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Robot-assisted gait training (RAGT) can provide a longer training duration with a higher repetition of stepping while maintaining a stable pattern of movement. However, the existing evidence of its effectiveness is not clear. The aim of this study is to investigate the feasibility and the effect of increased frequency (4 times per week) of RAGT compared to the most common frequency (2 times per week). we hypothesize that increased frequency of RAGT will result in greater improvements on the gait functions. This research will investigate the effect of increased frequency on robotic assisted gait training (RAGT) in a frequency of 4 times per a week, and will compare the effect of robotic assisted gait training (RAGT) with increased frequency and with usual frequency (2 times per a week) in regards with gait functional parameters such as balance, speed, endurance, and quality of gait among cerebral palsy (CP) children's.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05412485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Robotic assisted gait training
Trials testing the same drug.
- NCT06368180 — The Efficacy of a RAGT & BWSTT on Children With CP · NA · completed
Other recruiting trials for Cerebral Palsy Spastic Diplegia
Currently open trials in the same condition.
- NCT07534228 — Comparative Effects of Play-Based Therapy and NDT in Diplegic CP · NA · active not recruiting
Other University of Sharjah trials
Trials by the same sponsor.
- NCT07436507 — Effects of a Combined Home-Based Exercise Program on Dual-Task Gait Performance, EEG Markers of Cognitive-Motor Control, · NA · not yet recruiting
- NCT07434934 — Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis · NA · not yet recruiting
- NCT07009561 — Cortical Excitability and Typing Performance After Action Observation and Motor Execution · NA · not yet recruiting
- NCT06756256 — Effect of Foot Insole on Body Alignment, and in Stroke Patients · NA · completed
- NCT06762912 — The Short-term Effect of Low-load Resistance Training with Blood-flow Restriction on Somatosensory-evoked Potentials in · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05412485 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sharjah
- Last refreshed: 9 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05412485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing